These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 16622443)

  • 1. HER2 (ErbB2) receptors, a potential therapeutic target in squamous cell carcinoma of oesophagus.
    Khan AN; Yang W; Seifalian AM; Winslet MC
    Br J Cancer; 2006 Apr; 94(8):1213-4; author reply 1214-5. PubMed ID: 16622443
    [No Abstract]   [Full Text] [Related]  

  • 2. Correlation analysis of c-myc, p21(WAF/CIP1), p53, C-erbB-2 and COX-2 proteins in esophageal squamous cell carcinoma.
    Gomes TS; Noguti J; Forones NM; Lima FO; Dobo C; Fernandes Junior JA; Oshima CT; Ribeiro DA
    Pathol Res Pract; 2013 Jan; 209(1):6-9. PubMed ID: 23177619
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of HER2 gene amplification and protein expression in esophageal squamous cell carcinoma.
    Zhan N; Dong WG; Tang YF; Wang ZS; Xiong CL
    Med Oncol; 2012 Jun; 29(2):933-40. PubMed ID: 21318736
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Immunohistochemical study of epidermal growth factor receptor expression in esophageal squamous cell carcinoma].
    Delektorskaia VV; Chemeris GIu; Kononets PV; Grigorchuk AIu
    Arkh Patol; 2010; 72(5):3-6. PubMed ID: 21313757
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin-like growth factor-1 receptor as a novel prognostic marker and its implication as a cotarget in the treatment of human adenocarcinoma of the esophagus.
    Kalinina T; Bockhorn M; Kaifi JT; Thieltges S; Güngör C; Effenberger KE; Strelow A; Reichelt U; Sauter G; Pantel K; Izbicki JR; Yekebas EF
    Int J Cancer; 2010 Oct; 127(8):1931-40. PubMed ID: 20104520
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human epidermal growth factor receptor-2 in oesophageal cancers: an observational study.
    Al-Momani H; Barnes R; El-Hadi A; Shah R; Lewis WG; Edwards P
    World J Gastroenterol; 2012 Nov; 18(44):6447-51; discussion p.6450. PubMed ID: 23197890
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A new model system identifies epidermal growth factor receptor-human epidermal growth factor receptor 2 (HER2) and HER2-human epidermal growth factor receptor 3 heterodimers as potent inducers of oesophageal epithelial cell invasion.
    Fichter CD; Przypadlo CM; Buck A; Herbener N; Riedel B; Schäfer L; Nakagawa H; Walch A; Reinheckel T; Werner M; Lassmann S
    J Pathol; 2017 Dec; 243(4):481-495. PubMed ID: 28940194
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of miRNA-106a expression on the prognosis of patients with esophageal squamous cell carcinoma].
    Yuan JM; Mao WM; Luo J; Peng BF; Zheng ZG; Ling ZQ
    Zhonghua Zhong Liu Za Zhi; 2013 Aug; 35(8):590-4. PubMed ID: 24314216
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunohistochemical analysis on potential new molecular targets for esophageal cancer.
    Maurer J; Schöpp M; Thurau K; Haier J; Köhler G; Hummel R
    Dis Esophagus; 2014 Jan; 27(1):93-100. PubMed ID: 23551625
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MiR-193a-5p/ERBB2 act as concurrent chemoradiation therapy response indicator of esophageal squamous cell carcinoma.
    Lin CH; Tsai CH; Yeh CT; Liang JL; Hung WC; Lin FC; Chang WL; Li HY; Yao YC; Hsu TI; Lee YC; Wang YC; Sheu BS; Lai WW; Calkins MJ; Hsiao M; Lu PJ
    Oncotarget; 2016 Jun; 7(26):39680-39693. PubMed ID: 27203740
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpression and gene amplification of both ERBB2 and EGFR in an esophageal squamous cell carcinoma revealed by fluorescence in situ hybridization, multiplex ligation-dependent probe amplification and immunohistochemistry.
    Oyama T; Okamoto K; Nakamura R; Tajiri R; Ikeda H; Ninomiya I; Ooi A
    Pathol Int; 2015 Nov; 65(11):608-13. PubMed ID: 26314265
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Concurrent biological targeting therapy of squamous cell carcinoma of the esophagus with cetuximab and trastuzumab.
    Yamazaki M; Yamashita Y; Kubo N; Yashiro M; Ohira M; Ako E; Tanaka H; Muguruma K; Sawada T; Hirakawa K
    Oncol Rep; 2012 Jul; 28(1):49-54. PubMed ID: 22562413
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The predictive value of molecular markers (p53, EGFR, ATM, CHK2) in multimodally treated squamous cell carcinoma of the oesophagus.
    Sarbia M; Ott N; Pühringer-Oppermann F; Brücher BL
    Br J Cancer; 2007 Nov; 97(10):1404-8. PubMed ID: 17940507
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acantholytic squamous cell carcinoma of the oesophagus with prevalent single isolated tumour cells including signet ring cells and many osteoclast-like giant cells.
    Lee D
    Pathology; 2016 Apr; 48(3):281-3. PubMed ID: 27020507
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinical effect of E-series of prostaglandin receptor 2 and epidermal growth factor receptor signal pathways in the development of esophageal squamous cell carcinoma.
    Xu KK; Tian F; Chang D; Gong M; Fan JQ; Wang TY
    Dis Esophagus; 2014; 27(4):388-95. PubMed ID: 24883443
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic value of EGFR family expression in lymph node-negative esophageal squamous cell carcinoma patients.
    Yu W; Yang X; Chu L; Zhao K; Chen H; Xiang J; Zhang Y; Li H; Zhao W; Sun M; Wei Q; Fu X; Xie C; Zhu Z
    Pathol Res Pract; 2018 Jul; 214(7):1017-1023. PubMed ID: 29729836
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PTCH gene expression as a potential marker for esophageal squamous cell carcinoma.
    Ishiyama A; Hibi K; Koike M; Fujiwara M; Kodera Y; Ito K; Nakao A
    Anticancer Res; 2006; 26(1A):195-8. PubMed ID: 16475698
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased MMP-21 expression in esophageal squamous cell carcinoma is associated with progression and prognosis.
    Zhao Z; Yan L; Li S; Sun H; Zhou Y; Li X
    Med Oncol; 2014 Aug; 31(8):91. PubMed ID: 25015395
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical significance of hyperexpression of epidermal growth factor receptors (EGFR and HER-2) in esophageal squamous cell carcinoma.
    Delektorskaya VV; Chemeris GY; Kononets PV; Grigorchuk AY
    Bull Exp Biol Med; 2009 Aug; 148(2):241-5. PubMed ID: 20027338
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High expression of LAMP2 predicts poor prognosis in patients with esophageal squamous cell carcinoma.
    Li L; Wang W; Zhang R; Liu J; Yu J; Wu X; Xu Y; Ma M; Huang J
    Cancer Biomark; 2017 Jul; 19(3):305-311. PubMed ID: 28453465
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.